Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
…, L Scopece, V Mazzocchi, A Bacci… - … Journal of the …, 2009 - Wiley Online Library
BACKGROUND: A recent randomized study conducted on newly diagnosed glioblastoma (GBM)
patients demonstrated that concomitant and adjuvant temozolomide added to standard …
patients demonstrated that concomitant and adjuvant temozolomide added to standard …
O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence …
…, E Franceschi, A Tosoni, S Bartolini, A Bacci… - Neuro …, 2010 - academic.oup.com
O 6 -methylguanine DNA-methyltransferase (MGMT) promoter methylation status is a
prognostic factor in newly diagnosed glioblastoma patients. However, it is not yet clear whether, …
prognostic factor in newly diagnosed glioblastoma patients. However, it is not yet clear whether, …
The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3
…, L Morandi, V Monti, S Asioli, D Mazzatenta, A Bacci… - Endocrine, 2017 - Springer
The spectrum of corticotroph cell adenomas is very wide. Though rarely, silent corticotroph
cell adenomas (SCA) may transform into corticotroph cell adenomas associated with Cushing’…
cell adenomas (SCA) may transform into corticotroph cell adenomas associated with Cushing’…
A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s
…, M Faustini‐Fustini, L Morandi, A Bacci… - Clinical …, 2020 - Wiley Online Library
Objective Pituitary neuroendocrine tumours (PitNET)s can be aggressive, thus presenting
local invasion, postsurgical recurrence and/or resistance to treatment, responsible for …
local invasion, postsurgical recurrence and/or resistance to treatment, responsible for …
Granulomatous hypophysitis caused by a ruptured intrasellar Rathke's cleft cyst: report of a case and review of the literature
F Roncaroli, A Bacci, G Frank, F Calbucci - Neurosurgery, 1998 - journals.lww.com
OBJECTIVE AND IMPORTANCE: Ruptured Rathke's cleft cyst is a rare cause of giant cell
granulomatous hypophysitis. Chronic inflammatory reaction is caused by extravased cyst …
granulomatous hypophysitis. Chronic inflammatory reaction is caused by extravased cyst …
Peculiar pathological, radiological and clinical features of skull‐base de‐differentiated chordomas. Results from a referral centre case–series and literature review
S Asioli, M Zoli, F Guaraldi, G Sollini, A Bacci… - …, 2020 - Wiley Online Library
Aims De‐differentiated chordoma is an uncommon and incompletely characterised aggressive
neoplasm. Only a few cases originating from the skull base have been reported. Methods …
neoplasm. Only a few cases originating from the skull base have been reported. Methods …
Ophthalmoplegic migraine: from questions to answers
Introduction The International Classification of Headache Disorders classifies ophthalmoplegic
migraine (OM) under “cranial neuralgias and central causes of facial pain.” OM is …
migraine (OM) under “cranial neuralgias and central causes of facial pain.” OM is …
Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study
…, VP Fabbri, M Cellerini, A Bacci - The British journal of …, 2020 - academic.oup.com
Objective: Pituitary macroadenomas (PAs) are usually defined as benign intracranial tumors.
However, they may present local aggressive course. High Ki67 labelling index (LI) values …
However, they may present local aggressive course. High Ki67 labelling index (LI) values …
Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting …
…, D de Biase, M Zoli, M Faustini-Fustini, A Bacci… - Pituitary, 2015 - Springer
Purpose To assess the role of high sensitivity next-generation sequencing (NGS) of CTNNB1
for the diagnosis of adamantinomatous craniopharyngiomas (aCPs) and of BRAF for that of …
for the diagnosis of adamantinomatous craniopharyngiomas (aCPs) and of BRAF for that of …
Patient outcomes following second surgery for recurrent glioblastoma
…, R Poggi, S Bartolini, A Paccapelo, A Bacci… - Future …, 2016 - Future Medicine
Background: The most appropriate management of recurrent glioblastoma is still controversial.
In particular, the role of surgery at recurrence remains uncertain. Patients & methods: …
In particular, the role of surgery at recurrence remains uncertain. Patients & methods: …